Skip to Content

LCE 125 (Stalevo 125 31.25 mg / 200 mg / 125 mg)

Generic Name: carbidopa/entacapone/levodopa

Pill with imprint LCE 125 is Red, Elliptical / Oval and has been identified as Stalevo 125 31.25 mg / 200 mg / 125 mg. It is supplied by Novartis Pharmaceuticals.

Stalevo 125 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 125 31.25 mg / 200 mg / 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 125

Stalevo 125

Generic Name
carbidopa/entacapone/levodopa
Imprint
LCE 125
Strength
31.25 mg / 200 mg / 125 mg
Color
Red
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals
Inactive Ingredients
corn starch, croscarmellose sodium, glycerin, magnesium stearate, mannitol, polysorbate 80, sucrose, ferric oxide red, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00078-0545 Novartis Pharmaceuticals Corporation
00781-5641 Sandoz Inc.

Get help with Imprint Code FAQs.

Related Images for "LCE 125"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.